240
make-up, environmental factors or iatrogenic factors that include
therapies for breast cancer.
http://dx.doi.org/10.1016/j.ijom.2017.02.808Clinical and histopathological parameters for cervical lymph
node metastasis in oral squamous cell carcinoma
S. Ahmed
∗
, A. Ali, H. Shaikh, S. Jamal
Dow University of Health Sciences, Dow International Dental
College, Karachi, Pakistan
Objective:
To find useful markers for predicting late cervical
metastasis in patients with oral squamous cell carcinoma.
Methods:
The clinicopathological features of 50 consecutive
patients treated at Dow University Ojha Campus Hospital. Four
patients had T1 disease, 19 had T2 disease, and 7 had T3 and
20 had T4a disease. All patients were treated with extended or
modified type of neck dissection. Clinicopathological factors were
analysed to determine the factors predicting cervical lymph node
metastasis.
Results:
The clinicopathologic factors significantly associated
with the development of cervical lymph node metastasis were
tumour size, tumour depth, differentiation (moderate, microvas-
cular invasion, bone involvement, muscle invasion.
http://dx.doi.org/10.1016/j.ijom.2017.02.809e Fort I access for juvenile nasopharyngeal angiofibroma
treated without angiographic embolisation
S. Ahmed
∗
, Imran, A. Ali, Ateeq, J. Ashraf, S. Jameel
Dow International Dental College, Karachi, Pakistan
Objective:
Le Fort I for access for juvenile nasopharyngeal angi-
fibroma.
Result:
Total number of 18 male patients, age ranging from 9 to 20
years. Epistaxis was the commonest complaint of patient followed
by facial deformity, nasal obstruction, ophthalmologic symptoms,
patient was staged according to Fisch classification with most of
the patient in stage IVb. Other parameters to be seen in the study
were intraoperative blood loss and postoperative recurrence in 2
patients seen.
Conclusion:
Le Fort I provides good access to the base of skull
tumour without any scar or fistula formation.
http://dx.doi.org/10.1016/j.ijom.2017.02.810Methotrexate-associated lymphoproliferative disorder
considered as neck metastatic cancer: a case report
N. Aoki
∗
, H. Endoh, J. Baba, Y. Kosugi, M. Iida, T. Iwai,
I.I. Tohnai
Department of Oral and Maxillofacial Surgery, Saiseikai
Yokohamashi Nanbu Hospital, Japan
Objective:
Methotrexate-associated lymphoproliferative disorder
(MTX-LPD) has been reported these days. However, the devel-
opment of MTX-LPD in the neck lymph nodes has not been
previously described. We report a case of MTX-LPD considered
as neck metastatic cancer.
Case:
A 60-year-old man presented to our hospital with the chief
complaint of a severe swelling of the submandibular area. He had
a swelling for 2 months, but did not seek treatment at all. Due to
rheumatoid arthritis, he had been taking MTX 16 mg/week and
prednisolone 2 mg/day for 3 years.
Facial view showed asymmetric face showing a pus dis-
charging mass in the neck. Blood tests showed slightly elevated
C-reactive protein 2.0, highly elevated soluble interleukin-2 recep-
tor (sIL-2R) 1804. MTX was discontinued at initial visit because
his haematologist advised us watchful observation for 3 months
considering high possibility of MTX-LPD.
2 months after MTX withdrawal, the patients condition wors-
ened abruptly. Computed tomography revealed multiple swollen
lymph nodes in the neck. Consequently, biopsy of the neck was
performed to establish definitive diagnosis. The pathological diag-
nosis was diffuse large B-cell lymphoma, and MTX-LPD. The
result of fluorodeoxyglucose-positron emission tomography was
malignant lymphoma, stage I.
Results:
9 months after discontinuance of MTX and undergoing
chemotherapy, the multiple swollen lymph nodes had completely
disappeared.
Conclusions:
Recently, the incidence of MTX-LPD may increase
in oral surgery field becauseMTX therapy is the standard treatment
for rheumatoid arthritis. This case of neckMTX-LPD suggests that
the possibility of MTX-LPD should be considered even for neck
metastatic cancer in the patients treated with MTX.
http://dx.doi.org/10.1016/j.ijom.2017.02.811Clinicopathological profile of squamous cell carcinoma
presenting in a tertiary care hospital, Karachi
S. Asif
∗
, T. Ayub, N.R. Qureshi, S. Kanwal, A. Rehman,
Z. Abbas
Liaquat College of Medicine and Dentistry, Dar-ul-Sehat
Hospital, Karachi, Pakistan
Objective:
To assess the frequency of neck metastasis in different
staging and grading of squamous cell carcinoma (SCC).
Methods:
This study carried out in a tertiary care hospital and
included 60 patients from the year 2012–2015. Patients with recur-
rence disease and distant metastasis were excluded. 35 males and
25 females with SCC of different sites and stage were evaluated.
Clinically patients were staged as stage I, stage II, stage III and
stage IV and comprised of 30, 20, 2 and 8 patients, respectively.
Site distribution was buccal mucosa (31 patients), retromolar
region (12 patients), maxillary alveolus (8 patients), tongue (2
patients), floor of mouth (4 patients) and lip (3 patients). Right side
was most common (48 patients) as compared with the left side (12
patients), while lip cancer was in the upper lip in all patients includ-
ing commissure. All patients had undergone modified radical neck
dissection along with excision of primary tumour with 1 cm safe
margin. The tissue obtained and sent for histopathological analysis
and results obtained.
Results:
In stage I patients we observed that level I was positive
in 25 patients, level II was positive in 4 patients and no level was
positive in 1 patient. In stage II patients level I was positive in 8
patients, level II in 4 patients, levels I and II in 2 patients and no
level involvement in 1 patient. In stage III patients level I, II, III,
and IV was involved in both patients. In stage IV patients level II




